People · Operator
Named in public records as an officer, director or promoter · active 2009–2022 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| MycoTechnology, Inc. | — | Other Technology | Series C | $186.0M | $1.3B | 2015 |
| Synchrony Inc | — | Other Technology | Series A | $20.0M | $138.7M | 2009 |
| Ordaos, Inc. | — | Biotechnology | Series A | $16.8M | $1.3M | 2022 |
Scott Horner at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Scott Horner on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Sanjeev Krishnan | 1 | 11 |
| John Williamson | 1 | 10 |
| Ephraim Lindenbaum | 1 | 5 |
| Benjamin Britt | 1 | 5 |
| David Longo | 1 | 4 |
| Anthony Clark | 1 | 3 |
| Matthew Crisp | 1 | 3 |
| James Turk | 1 | 2 |
| Brian Loeb | 1 | 2 |
| Robert Schier | 1 | 2 |
| Oxana Kukhaneva | 1 | 2 |
| Jim Ellis | 1 | 2 |
| Victor Iannello | 1 | 2 |
| Robert Case | 1 | 2 |
| Daniel Sable | 1 | 2 |
| Ulo Palm | 1 | 1 |
| Eric McCarthey | 1 | 1 |
| Peter Lubar | 1 | 1 |
| James Ramey | 1 | 1 |
| John Lasko | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.